News & Updates

Show Multimedia Only

Mindfulness-based classes help fight depression during pregnancy, postpartum period

07 Dec 2022 by

A group-based mindfulness intervention during pregnancy appears to favourably affect the well-being of women, with the benefit persisting through the postpartum period, as shown in a recent study.

Mindfulness-based classes help fight depression during pregnancy, postpartum period

07 Dec 2022

Original New Drug Application Approvals by US FDA (16 - 30 November 2022)

05 Dec 2022

New drug applications approved by US FDA as of 16 - 30 November 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 30 November 2022)

05 Dec 2022

Valve dysfunction ups adverse outcomes risk in pregnant women with BPVs

24 Nov 2022

Structural valve dysfunction (SVD) has occurred in nearly one in four young women with bioprosthetic heart valves (BPVs) at the first antenatal visit, and this may have harmful effects in pregnancy outcomes, reports a study. Specifically, SVD of left-sided BPVs is associated with high rates of adverse events (AEs).

Valve dysfunction ups adverse outcomes risk in pregnant women with BPVs

24 Nov 2022

Coffee intake lowers risk of endometrial cancer

23 Nov 2022

Women who love to drink coffee will have more reason to do so following a study that reports an association between coffee consumption and a reduced risk of endometrial cancer, particularly among those with higher body mass index (BMI).

Coffee intake lowers risk of endometrial cancer

23 Nov 2022

Laparoscopic better than abdominal radical hysterectomy for cervical cancer

21 Nov 2022

Laparoscopic radical hysterectomy (LRH) leads to more positive outcomes than abdominal radical hysterectomy (ARH) in the treatment of cervical cancer, reveals a study.

Laparoscopic better than abdominal radical hysterectomy for cervical cancer

21 Nov 2022

Sleep apnoea, insomnia during pregnancy unrelated to infant outcomes

18 Nov 2022

Despite testing positive in unadjusted analyses, the impact of sleep apnoea and insomnia in pregnancy on infant outcomes appears nonsignificant, a recent study has found.

Sleep apnoea, insomnia during pregnancy unrelated to infant outcomes

18 Nov 2022

Long-term relugolix combo helps with heavy periods, anaemia in women with uterine fibroids

16 Nov 2022 by

Treatment with relugolix combination for up to 52 weeks yields sustained reductions in heavy menstrual bleeding as well as subsequent increases in iron stores in women with uterine leiomyomas, as shown in a study.

Long-term relugolix combo helps with heavy periods, anaemia in women with uterine fibroids

16 Nov 2022

Botox improves sexual function in women with provoked vestibulodynia

16 Nov 2022

Injections of botulinum toxin A (BTA) in women with provoked vestibulodynia (PVD) does not appear to reduce dyspareunia or pain at tampon use when compared with placebo at 12 months’ follow-up, reports a recent study. However, women on BTA have attempted intercourse more often and have better sexual function than those on placebo.

Botox improves sexual function in women with provoked vestibulodynia

16 Nov 2022

Pretreatment sarcopenic assessments help predict gynaecologic cancer outcomes

15 Nov 2022

Pretreatment sarcopenia appears to worsen survival in patients with gynaecologic cancers, such as ovarian (OC), endometrial (EC), and cervical (CC), reports a study. Including this assessment into cancer management may help improve prognosis.

Pretreatment sarcopenic assessments help predict gynaecologic cancer outcomes

15 Nov 2022

Original New Drug Application Approvals by US FDA (01 - 15 November 2022)

15 Nov 2022

New drug applications approved by US FDA as of 01 - 15 November 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01 - 15 November 2022)

15 Nov 2022

News & Updates

Showing Obstetrics & Gynaecology articles

Showing

Specialty:

Mindfulness-based classes help fight depression during pregnancy, postpartum period

Mindfulness-based classes help fight depression during pregnancy, postpartum period

Original New Drug Application Approvals by US FDA (16 - 30 November 2022)

Original New Drug Application Approvals by US FDA (16 - 30 November 2022)

Valve dysfunction ups adverse outcomes risk in pregnant women with BPVs

Valve dysfunction ups adverse outcomes risk in pregnant women with BPVs

Coffee intake lowers risk of endometrial cancer

Coffee intake lowers risk of endometrial cancer

Laparoscopic better than abdominal radical hysterectomy for cervical cancer

Laparoscopic better than abdominal radical hysterectomy for cervical cancer

Sleep apnoea, insomnia during pregnancy unrelated to infant outcomes

Sleep apnoea, insomnia during pregnancy unrelated to infant outcomes

Long-term relugolix combo helps with heavy periods, anaemia in women with uterine fibroids

Long-term relugolix combo helps with heavy periods, anaemia in women with uterine fibroids

Botox improves sexual function in women with provoked vestibulodynia

Botox improves sexual function in women with provoked vestibulodynia

Pretreatment sarcopenic assessments help predict gynaecologic cancer outcomes

Pretreatment sarcopenic assessments help predict gynaecologic cancer outcomes

Original New Drug Application Approvals by US FDA (01 - 15 November 2022)

Original New Drug Application Approvals by US FDA (01 - 15 November 2022)